S. Chavan

发表

Tumour lineage shapes BRCA-mediated phenotypes

N. Socci, B. Taylor, N. Schultz, 2019, Nature.

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Caleb K. Stein, O. Stephens, B. Barlogie, 2017, Nature Communications.

Towards the integration, annotation and association of historical microarray experiments with RNA-seq

Michael Anthony Bauer, Shweta S. Chavan, Erich A. Peterson, 2013, BMC Bioinformatics.

CD39 Identifies Tumor-Reactive CD8 T cells in Patients With Lung Cancer

Amanda R. Kulick, C. Rudin, J. Wolchok, 2022, bioRxiv.

WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC

C. Rudin, E. de Stanchina, J. Chan, 2022, Cell reports.

Genome-wide scan identifies variant in 2q12.3 associated with risk for multiple myeloma.

O. Stephens, V. Raj, A. Vangsted, 2014, Blood.

First-line pembrolizumab and trastuzumab in HER2-positive esophagogastric cancer

Donoghue, B. Taylor, N. Schultz, 2021 .

High Risk Multiple Myeloma Demonstrates Marked Spatial Genomic Heterogeneity Between Focal Lesions and Random Bone Marrow; Implications for Targeted Therapy and Treatment Resistance

Erich A. Peterson, O. Stephens, B. Barlogie, 2015 .

Multi-omic analysis of lung tumors defines pathways activated in neuroendocrine transformation

C. Rudin, J. Silber, C. Iacobuzio-Donahue, 2020, bioRxiv.

The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma

Caleb K. Stein, B. Barlogie, G. Morgan, 2017, Oncotarget.

The context-specific role of germline pathogenicity in tumorigenesis

B. Taylor, N. Schultz, M. Ladanyi, 2021, Nature Genetics.

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

O. Stephens, B. Barlogie, G. Morgan, 2017, Nature Communications.

Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing

B. Taylor, D. Solit, W. Tap, 2020, Clinical Cancer Research.

Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas

C. Brennan, B. Taylor, M. Ladanyi, 2019, Clinical Cancer Research.

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.

Erich A. Peterson, Caleb K. Stein, O. Stephens, 2016, Blood.

Prevalence and Characterization of Biallelic and Monoallelic NTHL1 and MSH3 Variant Carriers From a Pan-Cancer Patient Population

C. Bourque, B. Taylor, M. Berger, 2021, JCO precision oncology.

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

Erich A. Peterson, Caleb K. Stein, O. Stephens, 2017, Blood Cancer Journal.

Revealing the inherent heterogeneity of human malignancies by variant consensus strategies coupled with cancer clonal analysis

Erich A. Peterson, D. Johann, S. Chavan, 2014, BMC Bioinformatics.

The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer.

Amanda R. Kulick, C. Rudin, J. Wolchok, 2022, Immunity.

Leveraging CD39 To Identify Tumor-Reactive CD8 T cells In Human Lung Cancer

Maria R. Ward, Amanda R. Kulick, C. Rudin, 2022 .

Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor.

B. Taylor, C. Iacobuzio-Donahue, V. Reuter, 2020, The Journal of clinical investigation.

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial.

B. Taylor, N. Schultz, D. Solit, 2020, The Lancet. Oncology.

The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma

B. Barlogie, G. Morgan, W. Gregory, 2015, Clinical Cancer Research.

Inhibiting MEK in MAPK pathway-activated myeloma

B. Barlogie, G. Morgan, V. Miller, 2015, Leukemia.

An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.

O. Stephens, B. Barlogie, J. Shaughnessy, 2012, Blood.

NATbox: a network analysis toolbox in R

Radhakrishnan Nagarajan, Michael Anthony Bauer, Shweta S. Chavan, 2009, BMC Bioinformatics.

Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation

C. Rudin, N. Rekhtman, U. Bhanot, 2021, Journal of Hematology & Oncology.

Amplification of JNK Signaling Is Necessary To Complete the Murine Gammaherpesvirus 68 Lytic Replication Cycle

J. Forrest, V. Macleod, R. Edmondson, 2012, Journal of Virology.

Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy

C. Rudin, U. Bhanot, R. Koche, 2021, Cancer Research.

MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer

C. Rudin, E. de Stanchina, J. Poirier, 2021, iScience.

The Clinical Impact of Macrofocal Disease in Multiple Myeloma Differs Between Presentation and Relapse

B. Barlogie, G. Morgan, M. Zangari, 2016 .

Phosphoproteomic Analyses Reveal Signaling Pathways That Facilitate Lytic Gammaherpesvirus Replication

Shweta S. Chavan, Ricky D. Edmondson, J. Forrest, 2013, PLoS pathogens.

Mapping of international protein index to Affymetrix probe-set identifier for correlating genomics and proteomics expression profiles in multiple myeloma

Shweta S. Chavan, John D. Shaughnessy, Bart Barlogie, 2011, 2011 IEEE International Workshop on Genomic Signal Processing and Statistics (GENSIPS).

Overview of biological database mapping services for interoperation between different 'omics' datasets

Shweta S Chavan, John D Shaughnessy, Ricky D Edmondson, 2011, Human Genomics.

Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma

O. Stephens, B. Barlogie, E. Tian, 2015, Leukemia.

MiMSI - a deep multiple instance learning framework improves microsatellite instability detection from tumor next-generation sequencing

Ahmet Zehir, Thomas J. Fuchs, Shweta S. Chavan, 2020 .

A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3

O. Stephens, B. Barlogie, A. Vangsted, 2016, British journal of haematology.

Multi-omic analysis of lung tumors defines pathways activated in neuroendocrine transformation.

C. Rudin, J. Silber, C. Iacobuzio-Donahue, 2021, Cancer Discovery.

Enhancing cancer clonality analysis with integrative genomics

Erich A. Peterson, G. Morgan, D. Johann, 2015, BMC Bioinformatics.

Towards the integration, annotation and association of historical microarray experiments with RNA-seq

Erich A. Peterson, D. Johann, S. Chavan, 2013, BMC Bioinformatics.

Leveraging the new with the old: providing a framework for the integration of historic microarray studies with next generation sequencing

Erich A. Peterson, D. Johann, S. Chavan, 2014, BMC Bioinformatics.

Leveraging the new with the old: providing a framework for the integration of historic microarray studies with next generation sequencing

Michael Anthony Bauer, Shweta S. Chavan, Erich A. Peterson, 2014, BMC Bioinformatics.

Tumour lineage shapes BRCA-mediated phenotypes

N. Socci, B. Taylor, N. Schultz, 2019, Nature.

Role of CD38 in anti-tumor immunity of small cell lung cancer

C. Rudin, J. Chan, A. Chow, 2024, Frontiers in immunology.

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.

Erich A. Peterson, Caleb K. Stein, O. Stephens, 2016, Blood.